Facts and myths about radiopeptide therapy: Scylla, Charybdis and Sibyl

被引：9

作者：

Bodei, L ^{[1
]}

Chinol, M ^{[1
]}

Cremonesi, M ^{[1
]}

Paganelli, G ^{[1
]}

机构：

[1] European Inst Oncol, Div Nucl Med, I-20141 Milan, Italy

来源：

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2002年 / 29卷 / 08期

关键词：

D O I：

10.1007/s00259-002-0864-8

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：1099 / 1100

页数：2

共 13 条

[1]

Behr TM, 2002, EUR J NUCL MED MOL I, V29, P277, DOI 10.1007/s00259-001-0713-1

[2] Between the Scylla and Charybdis of peptide radionuclide therapy: hitting the tumor and saving the kidney [J].

Boerman, OC ;

Oyen, WJG ;

Corstens, FHM .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) :1447-1449

[3] Receptor-mediated radiotherapy with 90Y-DOTA-DPhe1-Tyr3-octreotide:: The experience of the European Institute of Oncology Group [J].

Chinol, M ;

Bodei, L ;

Cremonesi, M ;

Paganelli, G .

SEMINARS IN NUCLEAR MEDICINE, 2002, 32 (02) :141-147

[4]

Cremonesi M, 2001, J NUCL MED, V42, p246P

[5] Biokinetics and dosimetry in patients administered with 111In-DOTA-Tyr3-octreotide:: implications for internal radiotherapy with 90Y-DOTATOC [J].

Cremonesi, M ;

Ferrari, M ;

Zoboli, S ;

Chinol, M ;

Stabin, MG ;

Orsi, F ;

Maecke, HR ;

Jermann, E ;

Robertson, C ;

Fiorenza, M ;

Tosi, G ;

Paganelli, G .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (08) :877-886

[6] End-stage renal disease after treatment with 90Y-DOTATOC [J].

Cybulla, M ;

Weiner, SM ;

Otte, A .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (10) :1552-1554

[7] Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours:: comparison of 86Y-DOTATOC and 111In-DTPA-octreotide [J].

Förster, GJ ;

Engelbach, M ;

Brockmann, J ;

Reber, H ;

Buchholz, HG ;

Mäcke, HR ;

Rösch, F ;

Herzog, H ;

Bartenstein, P .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (12) :1743-1750

[8] [177Lu-DOTA0,Tyr3]octreotate:: comparison with [111In-DTPA0]octreotide in patients [J].

Kwekkeboom, DJ ;

Bakker, WH ;

Kooij, PPM ;

Konijnenberg, MW ;

Srinivasan, A ;

Erion, JL ;

Schmidt, MA ;

Bugaj, JL ;

de Jong, M ;

Krenning, EP .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (09) :1319-1325

[9]

McCarthy KE, 2000, Q J NUCL MED, V44, P88

[10] A new cause of renal thrombotic microangiopathy: Yttrium 90-DOTATOC internal radiotherapy [J].

Moll, S ;

Nickeleit, V ;

Mueller-Brand, J ;

Brunner, FP ;

Maecke, HR ;

Mihatsch, MJ .

AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 37 (04) :847-851

← 1 2 →